We Are Human’s Expert Team and Atlanta-Based Usability Lab Join ClariMed’s Growing Network; Founder Annmarie Nicolson Appointed as Principal
ClariMed, Inc., a global leader in human-centered medical device development and regulatory services, announced the strategic acquisition of We Are Human, a UK and US-based consultancy specializing in user-focused design and research in MedTech innovation. The acquisition expands ClariMed’s geographic reach into the Southeast through We Are Human’s state-of-the-art Atlanta research facility while advancing the company’s mission to enable innovative, human-centered medical technologies and make them accessible to communities that need them.
Health Technology Insights: iGan Partners Invests in DOCSI to Transform Surgical Supply Chain Optimization
Annmarie Nicolson, founder of We Are Human, will join ClariMed as Principal, bringing her extensive experience in early-stage formative research, contextual inquiry, and UX research for MedTech innovation to the leadership team. The acquisition brings the complete We Are Human team and their Atlanta research facility into the ClariMed family, expanding the company’s presence in the Southeast region.
Health Technology Insights: Rad AI Expands Team to Boost Growth in Radiology AI
“This acquisition represents our continued commitment to our user-centered foundation while expanding our reach and strengthening our capabilities,” said Kelley Kendle, CEO of ClariMed. “Regional variability allows us to better address our patients’ needs and advance our mission to make medical technology safer, more intuitive, and more impactful for the people who need it most. This isn’t just a merger of capabilities — it’s a deep alignment of values.”
The acquisition strengthens ClariMed’s position as an integrated medical device services partner, expanding specialized expertise in user experience research, regulatory compliance, and design validation across both US and UK markets. We Are Human brings ISO 13485 certification and extensive experience with IEC-62366 and FDA Guidance requirements, having conducted research with hundreds of healthcare professionals, lay persons and diverse patient groups. The Atlanta laboratory will serve as ClariMed’s newest research facility, offering access to diverse study populations in the Southeast while supporting the company’s growing client base.
“Joining ClariMed represents an exciting opportunity to amplify our impact in healthcare through human-centered research and design,” said Annmarie. “Both organizations have a long-standing commitment to putting users first and creating products that truly make a difference in people’s lives. This shared dedication to excellence and user-centered principles positions us to deliver even more meaningful solutions- both to our clients and, to the patients and healthcare providers who rely on innovative medical technology every day.”
The integration of We Are Human establishes ClariMed’s first Southeast location, joining strategic offices across the United States and internationally, including Chadds Ford, PA; Cambridge, MA; San Jose, CA; Cambridge, UK; Leeds, UK; and now Atlanta, GA. This expanded geographic network enhances ClariMed’s ability to serve global clients while accessing diverse talent pools and participant populations for user research and usability testing.
This acquisition aligns with ClariMed’s growth strategy of building comprehensive, human-centered solutions for medical device development. The combined expertise of both organizations positions ClariMed to better serve pharmaceutical and medical device manufacturers seeking to accelerate time to market while enhancing patient safety and user experience.
Health Technology Insights: UPMC-GoHealth Urgent Care Launches, Expanding Access to On-Demand Care
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source- PR Newswire
